When did Champions Oncology report Q1 2025 earnings?

Champions Oncology (CSBR) reported Q1 2025 earnings on March 11, 2025 after market close.

What were Champions Oncology's Q1 2025 revenue and EPS?

Champions Oncology reported revenue of $17.0M and diluted EPS of $0.31 for Q1 2025.

Revenue beat the consensus estimate of $12.0M by $5.0M. EPS beat the consensus estimate of $-0.01 by $0.32.

You can read the 10-Q periodic report (0001628280-25-012941) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported March 11, 2025 · After market close

Revenue estimate$12.0M

EPS estimate-$0.01

Jul 16, 2026 (In 3 weeks)

Revenue estimate$12.9M

EPS estimate-$0.05

Q1 2025$17.0MBeat by $5.0M

Q1 2025$0.31Beat by $0.32

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Champions Oncology report Q1 2025 earnings?: Champions Oncology (CSBR) reported Q1 2025 earnings on March 11, 2025 after market close.
What were Champions Oncology's Q1 2025 revenue and EPS?: Champions Oncology reported revenue of $17.0M and diluted EPS of $0.31 for Q1 2025.
Did Champions Oncology beat estimates in Q1 2025?: Revenue beat the consensus estimate of $12.0M by $5.0M. EPS beat the consensus estimate of $-0.01 by $0.32.
Where can I find Champions Oncology's Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001628280-25-012941) directly on SEC EDGAR. The filing index links above go to sec.gov.